Clinical Trial Update: Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of TLK286 administered weekly in advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TLK286

Snippet

Sponsor: Telik | Conditions: Carcinoma, Non-small-cell Lung | Phase 2 | Status: COMPLETED